Ypsomed Medical Device Manufacturing (Changzhou) Co., Ltd. is a *production base invested and established in the Asia-Pacific region by the Swiss Ypsomed Group, and was located in the Sino-Swiss (Changzhou) International Industrial Innovation Park in Changzhou High-tech District in October 2022. The Swiss Ypsomed Group is a * independent medical technology company in the field of self-injection, mainly engaged in the research and development, production and sales of products such as injection pens and autoinjectors. The Changzhou project broke ground in September 2023, and it took only 14 months for the main factory building to be completed. It was officially put into production on June 26, 2025, and plans to produce 100 million new portable self-administration injection devices annually. The goal is to build an internationally competitive innovation platform in the biopharmaceutical field and become a hub linking core European technologies with the Chinese application market. In July 2024, the Group increased its capital by 100 million euros within the existing plot to expand production capacity and invest in new product lines, bringing the total investment in Changzhou to 3 times the * initial plan; the Phase II project has been selected as a major implementation project in Jiangsu Province for 2026.
Products and Services
The company is mainly engaged in the research and development, production and assembly of medical injection pens and needles, and produces new portable self-administration injection devices. An injection pen is made from 15 components through fully automated processes such as injection molding, printing and assembly. The error of injection-molded parts is kept within 0.05 mm, and after reaching full production, it has an annual production capacity of 100 million self-administration injection devices. The products are mainly aimed at patients with chronic diseases, for self-injection by diabetic patients and people who want to lose weight. The pen tubes are pre-filled with drugs by pharmaceutical companies and then delivered to users around the world.
Honors and Qualifications
The company's new factory has passed the ISO 13485 Medical Device Quality Management System certification (certified by TÜV Süd) and obtained the internationally recognized LEED Platinum green building certification; in early 2026, it was rated as one of the top ten enterprises in the 2025 "Open Economy Contribution" category of Changzhou High-tech District; its Phase II project of new portable self-administration injection devices was selected as a major implementation project in Jiangsu Province for 2026.
Corporate Culture
General Manager Fei Leidu introduced that there is an open circle in the middle of the company's Logo, like the Chinese Taiji diagram, and also like Ypsomed growing together with Chinese partners. The company takes building an internationally competitive innovation platform in the biopharmaceutical field and becoming a hub linking core European technologies with the Chinese application market as its development goals, features the combination of Swiss precision manufacturing with Chinese intelligent manufacturing, and regards precision as the * greatest competitiveness of its products.
(This introduction is intelligently generated by DeepSeek AI and is for reference only.)
What does Ypsomed Medical Device Manufacturing (Changzhou) Co., Ltd. require? Who is Ypsomed Medical Device Manufacturing (Changzhou) Co., Ltd. hiring? recruitment: 工厂生产类占比最多占70%,其次是贸易/物流/采购/运输类占35%. What education can get in at ? 大专占比最多占60%,其次是高中占20%. Work experience required at ? 不限占比最多占85%,其次是1-3年占5%. Where are the job locations at ? 常州占比最多占100%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows